Vital Farms, Inc. (NASDAQ:VITL - Free Report) - Equities researchers at Telsey Advisory Group lowered their Q1 2025 earnings per share (EPS) estimates for Vital Farms in a research report issued on Friday, February 28th. Telsey Advisory Group analyst S. Vora now expects that the company will post earnings per share of $0.27 for the quarter, down from their prior forecast of $0.37. Telsey Advisory Group has a "Outperform" rating and a $52.00 price objective on the stock. The consensus estimate for Vital Farms' current full-year earnings is $1.11 per share. Telsey Advisory Group also issued estimates for Vital Farms' Q2 2025 earnings at $0.28 EPS, Q3 2025 earnings at $0.26 EPS, FY2025 earnings at $1.25 EPS, FY2026 earnings at $1.50 EPS and FY2027 earnings at $1.90 EPS.
A number of other research firms also recently weighed in on VITL. William Blair restated an "outperform" rating on shares of Vital Farms in a research note on Friday, February 28th. Jefferies Financial Group reduced their price target on Vital Farms from $45.00 to $41.00 and set a "buy" rating for the company in a research note on Monday, November 11th. Craig Hallum started coverage on Vital Farms in a research note on Friday, December 20th. They issued a "buy" rating and a $50.00 price target for the company. TD Cowen boosted their price target on Vital Farms from $41.00 to $45.00 and gave the company a "buy" rating in a research note on Wednesday, January 8th. Finally, Stifel Nicolaus raised Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 price objective for the company in a report on Friday, February 28th. Eight investment analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $44.57.
View Our Latest Research Report on Vital Farms
Vital Farms Stock Down 1.3 %
VITL stock traded down $0.39 during mid-day trading on Monday, reaching $30.39. The company had a trading volume of 1,034,735 shares, compared to its average volume of 966,450. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.24 and a quick ratio of 2.81. The stock has a 50 day simple moving average of $38.21 and a two-hundred day simple moving average of $35.69. The company has a market capitalization of $1.35 billion, a price-to-earnings ratio of 27.13 and a beta of 0.95. Vital Farms has a 52 week low of $19.22 and a 52 week high of $48.41.
Vital Farms (NASDAQ:VITL - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.23 earnings per share for the quarter, beating analysts' consensus estimates of $0.15 by $0.08. The firm had revenue of $165.99 million during the quarter, compared to the consensus estimate of $160.32 million. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%.
Insider Buying and Selling
In related news, CMO Kathryn Mckeon sold 12,300 shares of the business's stock in a transaction on Monday, January 13th. The stock was sold at an average price of $42.08, for a total transaction of $517,584.00. Following the sale, the chief marketing officer now owns 46,203 shares in the company, valued at $1,944,222.24. The trade was a 21.02 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Matthew Ohayer sold 24,000 shares of the business's stock in a transaction on Thursday, December 19th. The stock was sold at an average price of $38.19, for a total value of $916,560.00. Following the sale, the insider now owns 7,038,890 shares in the company, valued at $268,815,209.10. This represents a 0.34 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 190,202 shares of company stock worth $7,855,957 in the last 90 days. Insiders own 27.60% of the company's stock.
Institutional Investors Weigh In On Vital Farms
A number of hedge funds and other institutional investors have recently bought and sold shares of VITL. Wellington Management Group LLP grew its position in Vital Farms by 417.8% during the 4th quarter. Wellington Management Group LLP now owns 2,431,024 shares of the company's stock worth $91,625,000 after acquiring an additional 1,961,550 shares during the last quarter. Principal Financial Group Inc. grew its position in shares of Vital Farms by 78.7% in the 4th quarter. Principal Financial Group Inc. now owns 1,171,950 shares of the company's stock valued at $44,172,000 after buying an additional 516,139 shares during the last quarter. Lord Abbett & CO. LLC grew its position in shares of Vital Farms by 64.6% in the 4th quarter. Lord Abbett & CO. LLC now owns 1,058,753 shares of the company's stock valued at $39,904,000 after buying an additional 415,614 shares during the last quarter. Emerald Advisers LLC grew its position in shares of Vital Farms by 106.8% in the 3rd quarter. Emerald Advisers LLC now owns 706,440 shares of the company's stock valued at $24,775,000 after buying an additional 364,837 shares during the last quarter. Finally, Jupiter Asset Management Ltd. grew its position in shares of Vital Farms by 96.3% in the 4th quarter. Jupiter Asset Management Ltd. now owns 628,709 shares of the company's stock valued at $23,696,000 after buying an additional 308,425 shares during the last quarter. Institutional investors own 98.59% of the company's stock.
About Vital Farms
(
Get Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Featured Articles
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.